AR and metabolic disease: An experiment based on mouse granulosa cells showed that androgen receptor (AR)-binding enzyme phosphoglycerate kinase (PGK1) was highly expressed in PCOS mice, which could regulate glucose metabolism, triggering metabolic disorders in granulosa cells, as well as enhance AR stability and nuclear translocation, thus aggravating cytotoxicity of androgen [129].